IceCure Medical Income Statement (2020-2026) | ICCM

Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.64M0.68M1.38M0.75M0.77M0.63M0.94M0.71M0.94M0.33M1.25M0.74M1.01M0.66M0.88M0.72M0.53M0.85M1.28M0.91M
Cost of Revenue (Quarter)
0.38M0.32M-1.09M0.31M0.38M0.47M2.04M0.39M0.50M0.35M-0.34M0.47M0.48M0.43M0.46M0.51M0.39M0.57M0.68M0.62M
Gross Profit (Quarter)
0.25M0.36M0.64M0.43M0.38M0.17M0.46M0.32M0.43M-0.02M0.57M0.27M0.53M0.23M0.42M0.22M0.13M0.28M0.60M0.29M
Operating items
Research & Development (Quarter)
1.59M1.55M1.60M2.39M2.25M2.24M2.24M2.11M2.08M2.20M1.88M1.95M1.58M1.86M1.70M1.66M1.71M1.76M2.30M2.21M
Selling, General & Administrative (Quarter)
0.89M1.07M1.47M1.72M1.62M1.32M1.19M1.09M1.26M0.92M0.90M0.93M0.92M0.92M0.99M0.92M0.95M1.44M1.22M1.26M
Operating Expenses (Quarter)
2.48M2.62M3.07M4.11M3.88M3.56M3.43M3.20M3.34M3.12M2.78M2.88M2.50M2.78M2.69M2.59M2.66M3.20M3.52M3.47M
Operating Income (Quarter)
2.55M2.85M-16.32M4.42M4.28M4.10M-29.55M3.96M4.08M4.12M-27.74M3.65M3.23M4.29M4.53M3.66M3.38M3.84M4.22M4.25M
EBIT (Quarter)
2.55M2.85M-16.32M4.42M4.28M4.10M-29.55M3.96M4.08M4.12M-27.74M3.65M3.23M4.29M4.53M3.66M3.38M3.84M4.22M4.25M
Non-operating items
Non Operating Income (Quarter)
-0.08M0.04M-0.31M0.02M0.24M-0.04M-0.46M-0.19M-0.19M-0.12M1.43M-0.04M0.03M
Net income details
EBT (Quarter)
2.55M2.85M-16.32M4.42M4.28M4.10M-29.55M3.96M4.08M4.12M-27.74M3.65M3.23M4.29M4.53M3.66M3.38M3.84M4.22M4.25M
Profit After Tax (Quarter)
2.48M2.89M-16.63M-4.45M-4.52M-4.06M-3.95M-3.77M-3.89M-4.00M-3.00M3.61M3.08M4.15M-26.16M3.59M3.36M3.86M4.25M-4.27M
Income from Continuing Operations (Quarter)
2.55M2.85M-16.32M4.42M4.28M4.10M-29.55M3.96M4.08M4.12M-27.74M3.65M3.23M4.29M4.53M3.66M3.38M3.84M4.22M4.25M
Consolidated Net Income (Quarter)
2.55M2.85M-16.32M4.42M4.28M4.10M-29.55M3.96M4.08M4.12M-27.74M3.65M3.23M4.29M4.53M3.66M3.38M3.84M4.22M4.25M
Income towards Parent Company (Quarter)
2.55M2.85M-16.32M4.42M4.28M4.10M-29.55M3.96M4.08M4.12M-27.74M3.65M3.23M4.29M4.53M3.66M3.38M3.84M4.22M4.25M
Net Income towards Common Stockholders (Quarter)
2.55M2.85M-16.32M4.42M4.28M4.10M-29.55M3.96M4.08M4.12M-27.74M3.65M3.23M4.29M4.53M3.66M3.38M3.84M4.22M4.25M
Additional items
EPS (Basic) (Quarter)
0.02M0.01M-0.570.04M0.02M0.01M-0.800.05M0.02M0.02M-0.610.05M0.02M0.02M0.02M0.06M0.03M0.02M0.070.07M
EPS (Weighted Average and Diluted) (Quarter)
0.10-0.570.12-0.800.09-0.610.02M0.090.03M0.07
Shares Outstanding (Weighted Average) (Quarter)
156.00249.0028.55M120.00244.00354.0037.02M80.00170.00260.0045.64M80.00140.00220.00300.0060.00120.00180.0063.58M60.00
Shares Outstanding (Diluted Average) (Quarter)
24.70M28.55M36.81M37.02M45.62M45.64M140.0050.88M120.0063.58M
EBITDA (Quarter)
2.55M2.85M-16.32M4.42M4.28M4.10M-29.55M3.96M4.08M4.12M-27.74M3.65M3.23M4.29M4.53M3.66M3.38M3.84M4.22M4.25M